Is QUANTAIRA a Scam? An Honest Investigation Into the AI Trading Platform (2026 Review)

Is QUANTAIRA a Scam? An Honest Investigation Into the AI Trading Platform (2026 Review). Independent investigation | Updated 12 November 2026 | AI trading, cryptocurrency and consumer protection

QUANTAIRA promises AI-powered automated cryptocurrency trading, sophisticated technology and a community rewards programme. But is it a legitimate investment opportunity, or are there warning signs that prospective members should take seriously? I investigated the website, its technology partners, its connection to Daisy Global and the claims being made. Here is what I found.

Let’s get straight to the question.

Is QUANTAIRA a scam?

I cannot honestly tell you that it is. I have not found conclusive evidence proving that QUANTAIRA is operating a fraudulent scheme.

But I have also not found enough independently verifiable evidence to recommend joining it.

And there are some significant issues that I believe anyone considering the opportunity should understand.

This is not a review written to promote QUANTAIRA, earn referral commissions or encourage people to sign up.

It is an investigation into what is publicly known, what can be verified, and what remains unanswered.

Because when somebody is asking you to trust an automated trading platform with access to your money, they deserve more than an impressive presentation and a collection of promises.

1. What is QUANTAIRA and what is it promising?

QUANTAIRA describes itself as an AI-powered automated cryptocurrency trading platform.

Its promotional material identifies two technology partners:

• EndoTech: Associated with the quantitative trading algorithms and automated trading technology.

• CoinZoom: The cryptocurrency exchange infrastructure intended to support participants’ trading accounts.

The proposition is appealing.

Instead of learning how to trade cryptocurrency yourself, the technology supposedly analyses market conditions and executes trades automatically.

The marketing highlights:

• AI-powered automated trading.

• No upfront joining fee.

• Funds remaining in the participant’s exchange account.

• Automatic compounding.

• Community rewards.

• Referral opportunities.

• Access to quantitative trading technology.

The promotional material has also referred to a minimum trading amount of $10.

On paper, it sounds accessible.

But I would not confuse accessibility with safety.

The real questions are whether the technology works, whether the business is properly structured, whether the trading results can be verified and whether participants can actually access the advertised services.

Visit the official QUANTAIRA website.

2. The first major warning sign: Who actually operates QUANTAIRA?

This is one of the first things I would establish before considering any financial opportunity.

Who is the legal company behind QUANTAIRA?

Who owns it?

Who are its directors?

Where is it incorporated?

Which jurisdiction governs its activities?

These are basic questions.

Yet the public-facing information and legal documents available on the QUANTAIRA website have not given me sufficient information to establish a complete picture of the operating company’s legal identity and accountability.

There is another issue.

Earlier versions of the published Terms of Use and Privacy Policy contained placeholder contact fields, including:

• SUPPORT EMAIL – TO BE PROVIDED.

• PRIVACY EMAIL – TO BE PROVIDED.

These are details I would expect a professional platform inviting financial participation to have completed.

I would want to see a fully identified contracting company, a registered address, functioning customer support details and a clearly identified entity responsible for handling personal information.

A professional-looking website is not a substitute for knowing who you are dealing with.

3. The CoinZoom problem: Can UK residents actually participate?

This is probably the most immediately relevant issue for UK readers.

QUANTAIRA promotional material has described CoinZoom as the exchange where participants retain their funds.

Some promotional material has claimed availability in more than 160 countries.

However, CoinZoom’s own published eligibility information specifically lists the United Kingdom among countries in which it does not engage in business with resident customers.

Its help centre also states that accounts held by residents of prohibited countries may be closed.

This is not a rumour or an anonymous online complaint. It is information published by CoinZoom itself.

Read CoinZoom’s official country eligibility list.

This creates an obvious problem.

If QUANTAIRA is advertising a CoinZoom-based arrangement, how are UK residents supposed to participate?

Is another exchange being introduced?

Has CoinZoom changed its policy?

Is there a different legal arrangement?

I have not found satisfactory public evidence resolving this question.

Until there is written confirmation from CoinZoom and QUANTAIRA, I would advise UK residents not to attempt to bypass the exchange’s geographical restrictions.

This is a particularly important point because a platform can be advertised internationally without every component of its service actually being available in every country.

4. The Daisy Global connection: Why does it matter?

QUANTAIRA is being promoted through material associated with the Daisy Global community.

Daisy Global, also known as D.AI.SY, previously promoted an AI-driven trading proposition involving cryptocurrency, forex and EndoTech technology.

In November 2023, the British Columbia Securities Commission published an investor warning concerning Daisy Global.

The regulator stated that Daisy advertised crowdfunding packages directing between 50% and 100% of proceeds into investment funds trading forex and cryptocurrency using AI-driven algorithms.

It also stated that Daisy was not registered to trade in or advise on securities or derivatives in British Columbia.

Read the official BCSC warning.

The Canadian Securities Administrators subsequently included the warning in its investor alert database.

Read the Canadian Securities Administrators entry.

Why is this relevant?

Because EndoTech is the common technology name appearing in the historical Daisy proposition and the new QUANTAIRA promotion.

Daisy-related publications have also claimed that members have an equity interest in EndoTech and could receive dividends as the company grows.

Those ownership and dividend claims need independent verification.

I have not established the precise legal ownership arrangements or verified that all members who were promised equity actually received legally enforceable shares.

It would be wrong to assume QUANTAIRA is simply Daisy Global under a different name. I have not established that.

But the history is relevant, and prospective participants deserve to understand it.

5. EndoTech: Is the AI technology as safe as the marketing suggests?

EndoTech is presented as the technology provider behind QUANTAIRA.

Its website describes automated quantitative trading technology.

That is a legitimate area of financial technology.

However, I found some historical regulatory material that deserves attention.

In 2021, Belgium’s financial regulator, the FSMA, published a warning concerning companies offering automated trading software, including EndoTech.

The warning discussed unauthorised trading software services and risks associated with the distribution of these products.

Read the regulatory warning.

This is historical information. It does not establish that QUANTAIRA is acting unlawfully or that the current EndoTech technology is fraudulent.

There is also an FCA warning published in August 2025 against a firm called Endotechtrading, operating through endotechtrading.pro.

The FCA stated that this particular firm was unauthorised.

Importantly, I have not established that Endotechtrading is the same legal entity as the EndoTech technology provider associated with QUANTAIRA.

It would therefore be misleading to present that warning as an FCA warning against QUANTAIRA or automatically against EndoTech.

Read the FCA warning.

Nevertheless, I would want QUANTAIRA to explain precisely which EndoTech legal entity provides its technology and what regulatory permissions or exemptions apply to the arrangement.

6. Where is the proof that the AI trading system actually makes money?

This is perhaps the most important question of all.

QUANTAIRA’s marketing makes automated trading sound attractive.

But where are the independently verified trading results?

I would like to see:

I am particularly interested in the proposed EndoTech 2.0 technology and its Event Radar system.

The promotional material describes the use of technical and fundamental analysis.

That sounds interesting.

But sophisticated terminology does not establish profitability.

A system can be technologically advanced and still lose money.

A profitable backtest does not guarantee profitable live trading.

And a handful of successful trading screenshots tells us practically nothing about long-term performance.

I have not established independently audited live performance figures sufficient to recommend QUANTAIRA as an investment opportunity.

Until those figures are available, claims about profitability should be treated with caution.

7. The compensation plan: Is this primarily a trading business or a recruitment opportunity?

Another issue worth investigating is the community rewards structure.

Public promotional material has referred to:

• 15% of trading profits being returned to the community.

• 60% of trading fees being allocated to the community.

• Referral-based participation.

• Rewards for introducing new participants.

These are promotional claims, not figures I have independently verified against a complete contractual compensation plan.

There is nothing inherently wrong with referral commissions.

Many legitimate businesses reward customers for introducing new customers.

However, I would want to understand exactly how QUANTAIRA generates revenue and how the rewards are funded.

Here are the questions I would ask:

1. Are rewards paid from genuine realised trading profits?

2. Are referral commissions paid separately?

3. Can participants earn without recruiting?

4. What happens when the trading system loses money?

5. Are rewards guaranteed or variable?

6. Is there any requirement to maintain a minimum trading balance?

7. Does the business remain commercially viable without continuous recruitment?

A trading business should be able to explain its financial model clearly.

If the main attraction becomes building a referral network rather than the actual trading performance, I would want to understand why.

Is QUANTAIRA a Scam? An Honest Investigation Into the AI Trading Platform (2026 Review)

8. What does the QUANTAIRA website’s online reputation tell us?

I also looked at independent website reputation information.

ScamAdviser currently gives quantaira.ai a trust score of zero and recommends caution.

Its report identifies several factors:

• The domain was registered on 28 May 2026.

• The registrant’s identity is hidden through a privacy service.

• The website has limited traffic.

• The site operates in the cryptocurrency sector.

Read the ScamAdviser assessment.

I would not use this score as proof of fraud.

Automated website reputation systems can produce misleading results, particularly for new websites.

Domain privacy is also common among legitimate website owners.

But the report does reinforce the need for proper due diligence.

A relatively new financial platform with limited independent reputation and an undisclosed domain registrant should expect prospective customers to ask questions.

9. My QUANTAIRA scam assessment: The red flags

Here is how I would summarise the evidence.

The important point is that several of these issues are independently verifiable.

The CoinZoom restriction is particularly concerning for UK participants.

The historical Daisy Global warning is a genuine regulatory record.

The EndoTech regulatory material also exists.

But none of these facts, individually or collectively, establishes that QUANTAIRA itself is a scam.

That would require stronger evidence.

10. My final verdict: Would I join QUANTAIRA?

I am not prepared to recommend QUANTAIRA based on what is currently available.

The concept of AI-powered automated trading is perfectly plausible.

EndoTech’s technology may have genuine capabilities.

CoinZoom is an identifiable cryptocurrency exchange.

And QUANTAIRA may eventually establish itself as a legitimate platform.

But potential is not proof.

Before I changed my assessment, I would want to see:

• A fully identified legal operating company.

• Written confirmation of the EndoTech and CoinZoom arrangements.

• Confirmation of eligibility for UK residents.

• Independently verified live trading results.

• Full disclosure of historical drawdowns.

• The complete rewards and compensation plan.

• Clear contractual arrangements protecting participants.

Until then, my advice is to keep your money where it is.

11. What should you do if somebody invites you to join?

If a friend, colleague or online contact sends you a QUANTAIRA invitation, do not feel pressured to register simply because the opportunity is being described as exclusive or available for a limited time.

Ask for the legal company details.

Ask for independently verified trading results.

Check whether the exchange is available in your country.

Understand the API permissions.

Read the terms and conditions.

And never assume that somebody else’s enthusiasm means they have completed the necessary research.

If you are in the UK, you can also check the FCA Firm Checker and Warning List before dealing with a business offering financial services.

Visit the FCA Firm Checker.

If something goes wrong, knowing which legal entity you contracted with and what protections apply can make an enormous difference.

Final thoughts: People deserve to be protected

I have no objection to AI trading.

I have no objection to cryptocurrency.

I have no objection to people finding new ways to generate additional income.

What I do object to is the idea that people should be expected to commit their hard-earned money without being given the information they need to make an informed decision.

There are people who will see the words artificial intelligence, institutional-grade technology and automated trading and assume that the opportunity must be sophisticated and safe.

There are people who will trust the recommendation of a friend.

There are people who will join because they do not want to miss out.

And there are people who simply cannot afford to lose their savings.

Those people deserve better.

They deserve transparent company information, independently verified trading results, clear fee structures and honest explanations of the risks.

They deserve to know about relevant regulatory history.

And they deserve to be told when an advertised service may not even be available in their country.

My conclusion is simple: I cannot establish that QUANTAIRA is a scam, but I cannot recommend it as a credible investment opportunity either. There are too many unanswered questions.

If the company wants people to trust it, the best response is not another promotional presentation.

It is evidence.

And until that evidence is available, I would advise prospective participants to keep their money out.

People deserve to be protected.

Disclaimer: This is an independent editorial investigation based on publicly available information as at 12 November 2026. It is not financial or legal advice. No finding of fraud is made against QUANTAIRA, EndoTech or CoinZoom. Historical regulatory warnings relate to the entities and activities identified by the relevant regulators and should not be treated as findings against QUANTAIRA. Readers should verify current legal, regulatory and exchange arrangements before making financial decisions.

Publishing details